SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium

Mart M Lamers; Anna Z Mykytyn; Tim I Breugem; Nathalie Groen; Kevin Knoops; Debby Schipper; Romy van Acker; Petra B van den Doel; Theo Bestebroer; Charlotte D Koopman; Chantal Reusken; Mauro J Muraro; Corine H GeurtsvanKessel; Martin E van Royen; Peter J Peters; Jingshu Zhang; Bart L Haagmans.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-476898

Documentos relacionados

  1. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
  2. The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.
  3. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
  4. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
  5. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
  6. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
  7. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
  8. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
  9. Differential beta-coronavirus infection dynamics in human bronchial epithelial organoids.
  10. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.